Trials / Unknown
UnknownNCT02177552
Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma
Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma - Carboplatin, Docetaxel and Capecitabine (CTX) or Epirubicin, Oxaliplatin and Capecitabine: a Randomised Phase 2 Trial.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 98 (estimated)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to determine the effects of treatment with carboplatin, docetaxel and capecitabine in patients with incurable cancer of the esophagus or stomach.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carboplatin | |
| DRUG | Docetaxel | |
| DRUG | Capecitabine | |
| DRUG | Epirubicin | |
| DRUG | Oxaliplatin |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2019-08-01
- Completion
- 2019-11-01
- First posted
- 2014-06-27
- Last updated
- 2019-02-15
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02177552. Inclusion in this directory is not an endorsement.